HemaSphere
(Jun 2022)
P1002: ANTI-FIBROTIC ACTIVITY OF BMP2 IN BONE MARROW-DERIVED MESENCHYMAL STROMAL CELLS OF MYELOPROLIFERATIVE NEOPLASMS
- T. Subotički,
- E. Živković,
- O. Mitrović Ajtić,
- M. Vukotić,
- D. Đikić,
- T. Dragojević,
- D. Šefer,
- S. Bižić,
- J. F. Santibanez,
- M. Gotić,
- V. P. Čokić
Affiliations
- T. Subotički
- 1 Department for Molecular Oncology, Institute for Medical Research, National Institute of Republic of Serbia
- E. Živković
- 1 Department for Molecular Oncology, Institute for Medical Research, National Institute of Republic of Serbia
- O. Mitrović Ajtić
- 1 Department for Molecular Oncology, Institute for Medical Research, National Institute of Republic of Serbia
- M. Vukotić
- 1 Department for Molecular Oncology, Institute for Medical Research, National Institute of Republic of Serbia
- D. Đikić
- 1 Department for Molecular Oncology, Institute for Medical Research, National Institute of Republic of Serbia
- T. Dragojević
- 1 Department for Molecular Oncology, Institute for Medical Research, National Institute of Republic of Serbia
- D. Šefer
- 2 Clinic of Hematology, University Clinical Center of Serbia
- S. Bižić
- 2 Clinic of Hematology, University Clinical Center of Serbia
- J. F. Santibanez
- 1 Department for Molecular Oncology, Institute for Medical Research, National Institute of Republic of Serbia
- M. Gotić
- 3 Faculty of Medicine, University of Belgrade, Belgrade, Serbia
- V. P. Čokić
- 1 Department for Molecular Oncology, Institute for Medical Research, National Institute of Republic of Serbia
- DOI
-
https://doi.org/10.1097/01.HS9.0000846876.57509.68
- Journal volume & issue
-
Vol. 6
pp.
892
– 893
WeChat QR code